Sale is live|00:00:00
Avantel LtdQ1 FY25

Avantel Ltd

Q1 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • Avantel’s sales grew from ₹77 crore in 2021 to ₹248 crore in 2024-25, nearly 3x increase (300% growth).
  • Profit increased from ₹15 crore in 2021 to nearly ₹60 crore in 2024-25, about 4x growth.
  • Growth rate of 35-40% CAGR observed from 2020-21 to 2023-24.
  • For 2025-26 and 2026-27, growth expected to stabilize without such steep increases.
  • From 2027-28 onwards, steep growth anticipated again if 4-5 key opportunities convert.
  • Targeted turnover of around ₹500 crore by 2030 with potential 300% growth over 4 years.
  • SDR market worth ~₹3000 crore annually; Avantel aims top 3-5 position in SDR defense segment.
  • Major product deliveries and trials underway (HFSDRs, UHF SDRs, airborne SDRs).
  • IMAX (medical devices) seen as diversification for stable, long-term growth alongside defense.

Margin guidance

Category 3
  • Strong past growth: Sales grew from ₹77 crores in 2021 to ₹248 crores in 2024-25 (approx. 3x), and profit rose from ₹15 crores to nearly ₹60 crores (about 4x).
  • CAGR for sales and profit from 2020-21 to 2023-24 was around 35-40%.
  • Growth expected to stabilize over the next 2 years (2025-26, 2026-27) with less steep increases.
  • Post stabilization, from 2027-28 onwards, a steep growth trajectory is anticipated driven by 4-5 key opportunities.
  • Potential to achieve ₹500 crores turnover by 2030, implying over 300% growth from current levels within 4 years.
  • Growth will depend on converting key defense and medical technology projects successfully.
  • Emphasis on innovation and niche state-of-the-art products for Indian Defence and Med tech sectors to drive future profitability.

Sign up free to read the full earnings analysis

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Avantel Ltd and 1,400+ other companies.

Fundraise plans

Yes
  • The company has raised ₹80 crores through a rights issue for a new plant (Page 10).
  • Promoters have invested their personal funds as unsecured loans to support short-term cash flow needs (Page 13).
  • Proposals submitted to State Bank of India (SBI) and Canara Bank for working capital funding; sanction expected in a couple of months (Page 13).
  • The company plans to raise more bank guarantees (BG limits) to bid for large projects, leveraging strong collateral assets (Page 14).
  • Total capital expenditure so far includes ~₹30 crores for fixed assets and ₹8 crores for product development for IMAX division, with ambitions for further investment (Page 14).
  • No explicit new fundraise announced beyond these points, but promoters are open to further shareholding changes if shareholders are concerned (Page 14-15).

Order book

  • Avantel has secured multiple orders in the SDR (Software Defined Radio) segment, including:
  • - Delivered and supplied 1 kW HF SDRs to Indian Navy and shipyards.
  • - Completed trials for UHF SDR and UHF SATCOM SDR for Indian Navy ships.
  • - Selected by DEAL Dehradun for airborne SDRs for Indian Air Force; became L1 and technically qualified.
  • - Recently received a ₹14-15 crore development order from DRDO for new SDR products.
  • Large SDR orders are in the market, such as:
  • - Bell and other players have won SDR orders worth thousands of crores.
  • - Approximate SDR market size is ₹3000 crores per year.
  • - RFQ for 10,000 SDRs for vehicles like T90 and BMP2 are in process; Avantel's participation unclear.
  • The company is working on five iDEX defense projects focused on satellite communication.
  • Orderbooks include significant upcoming opportunities expected from FY 2026-27.

Capex plans

Yes
  • Avantel has invested close to ₹30 crores in fixed assets for IMAX, with ₹22 crores already spent on facilities including clean rooms; about ₹8 crores allocated for product development (Page 14).
  • New state-of-the-art facility built as shared in the annual report to support IMAX's growth and certification processes (Page 14).
  • ₹80 crores raised through rights issue for a new plant, supplementing the ₹8000 crores spent on the existing ECT plant, which is almost operational (Page 12).
  • Plans for another plant, possibly linked to antennas and high-power antenna manufacturing, costing around ₹50-60 crores, expected to start by mid-2025 (Page 10).
  • Facility for satellite ground stations and VSAT services at the ECT site expected to be operational by August 2025 (Page 4).
  • Capital allocation balances defence and IMED (IMAX medical equipment) divisions to leverage growth potential and stabilize revenues (Pages 14, 10).

How does Avantel Ltd rank vs peers in Aerospace & Defense?

Pro feature
1Avantel Ltd
Rev 3Mar 3

See full Aerospace & Defense sector rankings

Unlock with Pro

Want more stocks like Avantel Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio